AVVH — Avvaa World Health Care Products Share Price
- $2.17m
- $7.64m
- $0.03m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 440.18 | ||
Price to Sales | 54.72 | ||
EV to EBITDA | 154.12 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | 124.69% |
Financial Summary
Year End 31st May | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0 | 0.04 | 0.01 | 0.01 | 0.03 | n/a | n/a | -12.09% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
AVVAA World Health Care Products, Inc. is a Canada-based company. The Company is operating as a capital financing company for real estate borrowings. The Company operates through its wholly owned subsidiary, GoldQuest Capital, Inc. The subsidiary is a real estate lending company that specializes in syndicating first lien, asset-backed real estate mortgages in the residential, commercial, and industrial sectors.
Directors
- Miguel Sanchez PRE
- Ruth Brennan CFO
- Ankit Amin VPR
- Patrice Ashiofu VPR
- Luis Beita VPR
- Jean Garzon TRS
- Carey Cooley SEC
- Zang Li DRC
- Jun Wang DRC
- Last Annual
- May 31st, 2013
- Last Interim
- August 31st, 2013
- Incorporated
- June 3rd, 1998
- Public Since
- February 23rd, 2001
- No. of Employees
- 2
- Sector
- Banking Services
- Industry
- Financials
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 966,442,572

- Address
- Box 459, 1710 ShuswapAve, LUMBY, V0E2G0
- Web
- https://avvaaworldhealth.com/
- Phone
- +1 2503792727
- Auditors
- Davidson & Co LLP
Similar to AVVH
1867 Western Financial
Pink Sheets on Nasdaq
1895 Bancorp of Wisconsin
Pink Sheets on Nasdaq
1st Colonial Bancorp
Pink Sheets on Nasdaq
1st Summit Bancorp of Johnstown
Pink Sheets on Nasdaq
8000
Pink Sheets on Nasdaq
FAQ
As of Today at 19:27 UTC, shares in Avvaa World Health Care Products are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Avvaa World Health Care Products last closed at $0.00 and the price had moved by +38.89% over the past 365 days. In terms of relative price strength the Avvaa World Health Care Products share price has outperformed the S&P500 Index by +29.76% over the past year.
There is no consensus recommendation for this security.
Find out moreAvvaa World Health Care Products does not currently pay a dividend.
Avvaa World Health Care Products does not currently pay a dividend.
Avvaa World Health Care Products does not currently pay a dividend.
To buy shares in Avvaa World Health Care Products you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Avvaa World Health Care Products had a market capitalisation of $2.17m.
Here are the trading details for Avvaa World Health Care Products:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: AVVH
Based on an overall assessment of its quality, value and momentum Avvaa World Health Care Products is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avvaa World Health Care Products. Over the past six months, its share price has outperformed the S&P500 Index by +45.57%.
As of the last closing price of $0.00, shares in Avvaa World Health Care Products were trading +15.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Avvaa World Health Care Products PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Avvaa World Health Care Products' management team is headed by:
- Miguel Sanchez - PRE
- Ruth Brennan - CFO
- Ankit Amin - VPR
- Patrice Ashiofu - VPR
- Luis Beita - VPR
- Jean Garzon - TRS
- Carey Cooley - SEC
- Zang Li - DRC
- Jun Wang - DRC